Continuous subcutaneous insulin infusion halts prepregnancy DR progression: Study
France: Women having prepregnancy diabetic retinopathy (DR) treated with continuous subcutaneous insulin infusion (CSII) during and before pregnancy had a lower risk of DR progression, according to a recent study in the journal Diabetes Care.
The researchers suggests that women with type 1 diabetes should undergo ophthalmologic examination both before and during pregnancy. Women having severe prepregnancy diabetic retinopathy should be treated before planning pregnancy.
Pregnancy is associated with DR development and progression but DR incidence remains unclear. Julien Bourry, Lille University Hospital, Lille, France, and colleagues assessed the rate of DR progression and its predictors during pregnancies in type 1 diabetes patients.
The researchers reported the retrospective data from pregnancies in patients with type 1 diabetes followed in Lille, France (1997–2015). In cases of severe nonproliferative retinopathy or progression, eye examination was performed every 3 months or every month.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.